KKR Associates North America XI L.P., 10% Owner at PRA Health Sciences, Inc. (PRAH), sold 9,500,000 shares at $74.85 ($711.1M) on 2017-08-14, disclosed to the SEC on 2017-08-16.
Open-market sale of $711.1M PRAH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.